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Abstract
Purpose Cognitive behavior therapy (CBT) reduces cancer-related fatigue (CRF) in cancer survivors in the short term. We
examined fatigue levels up to 14 years after CBT.
Methods Eligible participants of two randomized controlled trials who had completed CBT for CRF and a post-treatment
assessment were contacted (n = 81). Fatigue was assessed with the subscale “fatigue severity” of the Checklist Individual
Strength (CIS-fatigue). The course of fatigue over time was examined with linear mixed model analyses. Fatigue levels of
participants were compared to matched population controls at long-term follow-up. We tested with multiple regression
analysis if fatigue at follow-up was predicted by the patients’ fatigue level and fatigue-perpetuating factors directly after
CBT (post-CBT).
Results Seventy-eight persons completed a follow-up assessment (response rate = 96%, mean time after CBT = 10 years).
The mean level of fatigue increased from 23.7 (SD = 11.1) at post-CBT to 34.4 (SD = 12.4) at follow-up (p < 0.001).
Population controls (M = 23,9, SD = 11.4) reported lower fatigue levels than participants. Half of the patients (52%) who
were recovered from severe fatigue at post-CBT (CIS-fatigue < 35) were still recovered at long-term follow-up. Patients
with lower fatigue levels at post-CBT were less likely to show relapse.
Conclusion Despite initial improvement after CBT, levels of fatigue deteriorated over time. Half of the patients who were
recovered from severe fatigue after CBT still scored within normal ranges of fatigue at long-term follow-up.
Implications for Cancer Survivors It should be explored how to help patients with a relapse of severe fatigue following an
initially successful CBT. They may profit from CBT again, or another evidence-based intervention for fatigue (like
mindfulness or exercise therapy). Future research to gain insight into reasons for relapse is warranted.
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Are the effects of cognitive behavior therapy for severe fatigue
in cancer survivors sustained up to 14 years after therapy?
Introduction
Fatigue is one of the most common and distressing conse-
quences of cancer and cancer treatment. Cancer-related fa-
tigue (CRF), defined by the National Comprehensive Cancer
network (NCCN) as “a persistent, subjective sense of tired-
ness related to cancer or cancer treatment that interferes with
usual functioning, arises over a continuum, ranging from
tiredness to exhaustion. When compared to the tiredness felt
by a healthy individual, cancer-related fatigue is perceived of
greater magnitude, disproportionate to activity and exertion,
and not completely relieved by rest [1].” CRF has negative
effects on the patients’ quality of life. Prevalence rates of CRF
vary, approximately 25–30% of the cancer survivors report
persistent fatigue after cancer treatment [2, 3].
The cognitive-behavioral model of CRF makes a dis-
tinction between precipitating and perpetuating factors of
fatigue. It is assumed that cancer and its treatment trigger
fatigue, but that cognitive and behavioral factors perpetu-
ate it. Six perpetuating factors are distinguished: (1) in-
sufficient coping with the experience of cancer, (2) exces-
sive fear of disease recurrence, (3) dysfunctional cogni-
tions concerning fatigue, (4) deregulation of the sleep-
wake pattern, (5) deregulation of activity or low activity,
and (6) perceived lack of social support and negative so-
cial interactions [4].
Cognitive behavior therapy (CBT) for CRF is aimed at
these fatigue-perpetuating cognitions and behaviors. The effi-
cacy of CBT for CRF has been tested in several randomized
controlled trials (RCT’s) [4–6]. It was found that CBT led to
significant reduction of fatigue and functional impairment in
severely fatigued cancer survivors. Positive effects of CBT
were maintained up to 2 years after completion of CBT [7],
with the majority of patients reporting a level of fatigue within
normal range following treatment.
It is unclear if treatment effects are maintained in the
long-term; there are no studies on CBT in cancer survi-
vors that expanded the scope of the follow-up beyond the
aforementioned period of 2 years. Studies on the long-
term effect of CBT for fatigue in other patient populations
have shown that sustainment of treatment effect is not
self-evident.
For example, Janse et al. [8] recently reported on the long-
term effect of CBT for chronic fatigue syndrome (CFS).
Patients with CFS suffer from medically unexplained severe
fatigue. The long-term outcome was assessed in 583 partici-
pants of four previously published studies reporting on the
effects of CBT for CFS. Positive effects of CBT were
sustained up to 18 months after CBT. At long-term follow-
up, up to 10 years after end of treatment, fatigue severity had
significantly increased. The percentage participants with a fa-
tigue score in the normal range was substantially lower com-
pared to the short-term follow-up. Similar results were found
by Van Akker et al. in patients with multiple sclerosis [9].
Their study showed a positive effect of CBT on fatigue fol-
lowing treatment, which was also not sustained at follow-up.
The main objective of this study was to determine whether
the positive effect of CBT on fatigue severity in cancer survi-
vors was sustained at long-term follow-up. The second objec-
tive of this study was to determine predictors of fatigue sever-
ity at long-term follow-up. Knowledge on which patients are
vulnerable for a relapse of severe fatigue and whether relapse
is related to the presence of fatigue-perpetuating factors at
post-treatment would be valuable to optimize the intervention.
Material and methods
Study design and participants
In our study, we defined long-term follow-up as more than
2 years after finishing CBT for CRF. Participants were derived
from two previous RCTs of Gielissen et al. [4] and Prinsen
et al. [5]:
& In the RCT of Gielissen et al. [4], a total of 112 patients
were randomized to either CBT or waiting list condition.
Patients from both conditions received CBT, either direct-
ly after randomization or after the waiting list period. Of
the 112 patients, 98 started CBT and 70 completed the
post-treatment assessment. These 70 patients were invited
to participate in the current follow-up study.
& In the RCT of Prinsen et al. [5], 50 patients were random-
ized to either CBTor a waiting list. At second assessment,
the CBT of a number of patients was still ongoing.
Although the CBT continued, the study was stopped and
these patients had no post-CBT assessment. Only 23 ran-
domized patients from the intervention condition were
included in the analyses to determine the efficacy of
CBT [5]. We invited these 23 patients to participate in
the follow-up study.
A total of 93 patients (70 from the Gielissen study and 23
from the Prinsen study) were invited to participate in the study.
The initial RCTs had the following inclusion criteria: (1) being
severely fatigued at baseline (operationalized as a score of 35
or higher on the fatigue subscale of the Checklist Individual
Strength (CIS), (2) no known somatic cause for the fatigue, (3)
completion of curative treatment for cancer at least 1 year ago,
(4) a minimal age at disease onset of 18 years, (5) no evidence
of disease recurrence, and (6) not being older than 65 years [4,
5]. In the current follow-up study, we excluded patients who
had metastatic cancer and/or received treatment for cancer in
the 6 months prior to the follow-up assessment. Patients were
treated for mixed cancer diagnosis.
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Because general population surveys have shown that fa-
tigue increases with advancing age [10], we examined if fa-
tigue levels of our participants at long term follow-up differed
from the level of fatigue in an age-matched control group that
represented the general Dutch population.We assessed wheth-
er patients treated with CBT for CRF experienced a compara-
ble level of fatigue. A sample of general population controls
was derived from a research panel of CentERdata, a research
institute at Tilburg University. CentERdata has access to a
large panel of participants for surveys. The panel reflects the
distribution of the Dutch population with respect to age, sex,
education level, and socioeconomic status. For each partici-
pant in our study, three controls were derived from the re-
search panel. The control group was matched to our study
population based on age and gender with the procedure
Coarsened Exact Matching (CEM) using STATA/SE12.1.
Intervention
CBT for CRF is protocolized and aimed at the aforementioned
fatigue-perpetuating factors [4]. CBT starts with educating
patients about the cognitive-behavioral model of CRF.
Treatment is tailored: the relevant perpetuating factors are
assessed through use of specific questionnaires. The patient
formulates treatment goals and then starts with regulating the
sleep-wake pattern. This is followed by reformulating fatigue-
related beliefs and a graded activity program. Low active pa-
tients gradually increase their level of physical activity; rela-
tively active patients first learn to divide their activities more
evenly before the start of the graded activity program. If indi-
cated, excessive fear of cancer recurrence, insufficient coping
with cancer, and cancer treatment are addressed. It is also
discussed how to deal with a perceived lack of support with
respect to fatigue and how to reduce negative interactions.
During therapy, patients realize their goals step by step follow-
ed by an evaluation of the treatment. The mean number of
therapy sessions during the 6-month period was 12.5 (SD
4.7) in the intervention condition and 12.4 (SD 4.6) in the
waiting list condition in the Gielissen study [4] and 12.0 (SD
5.0) in the Prinsen study [5]. A detailed description of the
conditions and followed procedures concerning both studies
can be found in the original published papers [4, 5].
Procedures
The municipal registration was consulted in case of un-
known address and for the purpose of preventing ap-
proaching the family of deceased participants. An invitation
letter and follow-up questionnaires were sent by mail.
Patients who did not respond within a timeframe of 2 weeks
received the questionnaires again and were contacted by
phone simultaneously. Non-responders that could not be
reached by phone were sent a reminder by mail up to five
times. When patients did not want to fill in questionnaires,
they were asked to complete only the primary outcomemea-
sure, the subscale Fatigue Severity of the Checklist
Individual Strength (CIS-fatigue) by phone. The local med-
ical ethical committee Arnhem-Nijmegen approved the
study (registration number: 2015-2048).
Assessment
Patient characteristics
Sociodemographic and medical data were collected by a self-
report questionnaire. Data on work status and recent life
events were gathered. Patients were asked if they were cur-
rently treated for fatigue, received treatment by a psychologist
or psychiatrist, had seen a specialist for a somatic comorbidity
other than cancer, had a recurrence of cancer since their treat-
ment with CBT for CRF, and/or were treated for cancer in the
past 6 months.
Fatigue severity was assessed with the subscale Fatigue
Severity of the Checklist Individual Strength (CIS-fatigue),
indicating the level of fatigue in the previous 2 weeks, mea-
sured with eight items on a seven-point scale (range 8–56). A
score of 35 or higher indicates severe fatigue. The CIS is
found to be a reliable and valid instrument with a high internal
consistency: Cronbach’s alpha ranges from 0.92 to 0.95 in
cancer survivors [11].
Physical functioning, mental health, and bodily pain were
assessed with the respective subscales of the Short Form-36
(SF-36) [12]. Physical functioning at follow-up was mea-
sured, because the negative effect of fatigue on physical func-
tioning is well known and CBT had a positive effect on phys-
ical functioning in the two RCTs [4, 5].Mental health and pain
were measured as potential confounders of the long-term ef-
fect of CBT on fatigue severity. Weighted subscale scores
range from 0 to 100, with higher scores indicating a better
health status. The SF-36 is a valid and reliable instrument
for different patient populations [13].
Perpetuating factors of fatigue directly after CBT
The model of CBT for CRF comprises six perpetuating fac-
tors. During CBT, each of the relevant perpetuating factors is
targeted with a specific treatment module. We examined
whether the level of fatigue at long-term follow-up could be
predicted by the fatigue-perpetuating factors and the patients’
level of fatigue directly after CBT. The dataset we used did not
include a consistent useable measure of “fear of cancer recur-
rence,” one of the six perpetuating factors, that was used in
both studies. Therefore, this perpetuating factor was left out of
our analyses. We included the other five perpetuating factors
of fatigue, measured post-CBT, as possible predictors of fa-
tigue at long-term follow-up:
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– Deregulated activities: self-reported activity level was
measured with the activity subscale of the CIS.
– Coping with the experience of cancer (i.e., the extent to
which a subject is currently occupied with the coping
process after cancer and its treatment) was measured with
the Dutch version of the Impact of Event Scale (IES) [14].
– Dysfunctional cognitions: self-efficacy with respect to fa-
tigue (i.e., confidence in one’s own ability to cope with fa-
tigue) wasmeasuredwith the Self-Efficacy Scale (SES) [15].
– Deregulated sleep-wake cycle: sleep disturbances were
measured with the sleep/rest subscale of the Sickness
Impact Profile-8 (SIP-8) [16].
– A perceived lack of social support: discrepancies between
amount of received and desired amount of social support
were measured with the subscale “discrepancies” (i.e.,
discrepancies between amount and desired amount of so-
cial support) of the van Sonderen Social Support
Inventory (SSL-D) [17].
Statistical analyses
Data analyses were performed using SPSS (version 22). The
threshold for significance was p < 0.05 (two tailed). Sample
characteristics were analyzed using frequencies, percentages,
and mean scores.
Each participant had data of three measurement points: base-
line, post-CBT, and long-term follow-up. Analyses were con-
ducted for both fatigue and physical functioning as continuous
variables and for fatigue as a dichotomous variable (within
normal range < 35, outside normal range 35 or higher).
Sustainment of effects of CBT on fatigue severity
and physical functioning
We used linear mixed model analyses to examine the course
of fatigue and physical functioning over time with three as-
sessments clustered within each participant. Time was in-
cluded as a categorical variable (using dummy variables) to
compare scores at long-term follow-up assessment with the
scores at the baseline and post-CBTassessments. Because of
the extensive span of the follow-up period, it was important
to take into account that besides cancer and its treatment,
manyother factors can cause andperpetuate fatigue. For both
outcomes, additional analyses were conducted to assess the
influence of the following covariates on the development of
fatigue over time: somatic comorbidities (yes/no), cancer
recurrence (yes/no), significant life events (yes/no), pain
(subscale SF-36), and mental health (subscale SF-36). A re-
cent review by Abrahams et al. [18] has shown these factors
to be of importance in CRF.
The same analyses (with and without covariates) were con-
ducted with fatigue as a dichotomous outcome (i.e., within or
outside normal ranges) using logistic generalized estimating
equations (GEE). It was not possible to calculate the time
effect between baseline and follow-up, as only severely fa-
tigued patients (CIS-fatigue ≥ 35) were eligible to participate
in the trials. All patients were severely fatigued at baseline,
i.e., had a score of one. This lack of variance made it impos-
sible to estimate proper regression coefficients.
Comparison of fatigue level of participants
with the general population
The fatigue level of the participants at long-term follow-up
was compared with the fatigue level of general population
controls using a t test for independent samples.
Determining predictors of fatigue severity
at long-term follow-up
We performed multiple regression analyses (method enter)
to determine whether fatigue severity at long-term follow-
up (dependent variable) was predicted by fatigue severity
(block 1) and/or the fatigue-perpetuating factors measured
at post-CBT (poor coping with cancer/treatment, activity
regulation, dysregulation of sleep, dysfunctional cogni-
tions, a perceived lack of social support, and fatigue sever-
ity) (block 2).
In a post hoc analysis, we used the mean CIS-fatigue score
of the population control group (M = 24, SD = 11) as a refer-
ence point to divide our participants in the following two
groups: a low fatigue group (CIS-fatigue < 24) and a high fa-
tigue group (CIS-fatigue ≥ 24). By performing a chi-squared
test, we determined if patients in the low fatigue group were
less likely to relapse (CIS-fatigue ≥ 35 at long-term follow-up)
than patients in the high fatigue group.
Results
Of the 93 eligible patients, nine had died. We invited 84 pa-
tients to participate and excluded three participants: two pa-
tients were excluded because they reported to have received
cancer treatment in the 6 months prior to follow-up and one
patient was in the process of medical diagnostics because of
possible cancer recurrence. In addition, three patients did not
participate: one patient did not respond, and for two patients
no contact details were available. A total of 78 patients partic-
ipated in the study (78/81; response rate 96%) (see Fig. 1 for
the flowchart of patient inclusion).
Mean age at long-term follow-up was 55.1 years (SD =
10.1), 38 participants were female (49%), and the majority
of our participants were married or living together (76%). Of
the total group, 24 participants (31%) had experienced a sig-
nificant life event in the 3 months prior to the study and 32
522 J Cancer Surviv (2018) 12:519–527
participants (41%) reported the presence of a somatic comor-
bidity (see also Table 1).
Sustainment of effects of CBT on fatigue severity
and physical functioning
Linear mixed model analyses showed that fatigue levels had
increased at long-term follow-up compared with post-CBT
assessment (mean change = 10.7 points, p < 0.001). This time
effect remained significant when the covariates were added.
Lower mental health and higher pain scores predicted higher
fatigue levels over time (Table 3). Fatigue levels at long-term
follow-up were still lower compared the baseline assessment
(see also Table 2, mean change = − 12.5 points, p < 0.001)
after adding the covariates to the model. Results were largely
similar when comparing severely and non-severely fatigued
patients in logistic GEE analyses. Time effects were compa-
rable, but only pain was a significant covariate in this analysis.
Higher pain levels predicted higher levels of fatigue over time
(supplementary Table 1). In the previous two RCTs, 65 of 78
participants (83%) were recovered from severe fatigue (CIS-
fatigue < 35) directly after CBT. A total of 34 of these 65
participants (52%) were still recovered at long-term follow-
up. Of the 13 participants (17%) that did not recover from
severe fatigue directly after CBT, 11 participants were still
severely fatigued at long-term follow-up whereas 2 partici-
pants (15%) were recovered.
Physical functioning scores at long-term follow-up were
improved compared to the baseline assessment (SF-36 mean
change = 9.1 points, p < 0.001). However, the level of
physical functioning (SF-36) was decreased at long-term fol-
low-up compared with post-CBT assessment (SF-36 mean
change = − 9.7 points, p < 0.001). After controlling for covar-
iates, there was no significant reduction in levels of physical
functioning between post-CBTassessment and follow-up any-
more. Pain and somatic comorbidities predicted physical func-
tioning over time (Table 3).
Comparison of fatigue level of participants
with the general population
The participants’ fatigue scores at long-term follow-up were
significantly higher than fatigue scores in the sample of the
general population matched on age and gender (resp. CIS-
fatigue severity M = 34.4 SD = 12.4 vs. M = 23,9, SD = 11.4,
p = 0.01).
Determining predictors of fatigue severity
at long-term follow-up
The blockwise linear regression analysis showed that fatigue
at long-term follow-up was predicted by the level of fatigue
directly after CBT (Table 4). None of the perpetuating factors
at post-CBT assessment predicted fatigue severity at long-
term follow-up.
When comparing the low and high fatigue group at follow-up,
patients in the low fatigue group at post-CBT assessment were
less likely to be severely fatigued at follow-up (p< 0.05).
93 eligible patients
Excluded patients
2 patients with metastatic tumor after CBT
1 possible cancer recurrence
Non-participants
1 no response after consent
1 not locatable
1 patient emigrated
Excluded patients
9 deceased
84 patients invited to participate
78 patients completed the
questionnaires (96%)
CBT completers
70 from the Gielissen study
23 from the Prinsen study
Fig. 1 Flowchart of patient
inclusion
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Discussion
This study was the first to investigate the long-term effects of
CBT for CRF in cancer survivors. Although the significant
improvement in fatigue levels following CBTwere sustained
up to 2 years after therapy, fatigue levels again increased over
a longer time period. At long-term follow-up up to 14 years
after therapy, fatigue levels had deteriorated and were higher
than in general population controls. This deterioration could
not be explained by cancer recurrence, significant life events,
somatic comorbidities, pain, or a reduced mental health.
Nevertheless, at long-term follow-up, positive effects of
CBT on fatigue were sustained in a substantial subgroup.
Half of the patients (51%) who were recovered from severe
fatigue at post-CBT were still recovered at long-term follow-
up. Patients with a lower fatigue level at post-CBT were less
likely to show relapse.
Just like the levels of fatigue, levels of physical functioning
also showed deterioration between post-CBT assessment and
follow-up. However, this time effect was no longer significant
after correction for covariates, with pain and comorbidities
predicting physical functioning over time. We think that these
results indicate that the positive effects of CBT for CRF on
physical functioning are maintained at long-term follow-up.
As previous studies have shown that higher levels of fatigue
are associated with a reduced physical functioning [18], it is
remarkable that the deterioration of fatigue levels over time
did not go together with a worsening of the patients’ level of
physical functioning.
The significant relationship between fatigue severity direct-
ly after CBTand fatigue levels at long-term follow-up needs to
be replicated, but could have clinical implications. Reducing
fatigue severity as much as possible during therapy may im-
prove the long-term effectiveness of CBT. This suggests that it
may be beneficial to continue treatment with CBT as long as
the fatigue level decreases. A maximum reduction of the fa-
tigue level is not a treatment goal in itself in the current treat-
ment protocol for CBT for CRF.
The finding that there is relapse in a subgroup of patients at
long-term follow-up of CBT has been previously found in
several studies and in a variety of conditions. Our results show
similarities with the study of Janse et al. on the long-term
effects of CBT for patients with chronic fatigue syndrome
(i.e., medically unexplained severe fatigue) [8].
Understanding factors and mechanisms that determine the
long-term effect of CBT is crucial for the improvement of the
existing treatment protocol and for identifying patients at risk
for a relapse of CRF. After correction for covariates, fatigue
still deteriorated over time. It is poorly understoodwhy fatigue
levels increased. To understand the reasons for relapse, longi-
tudinal studies incorporating qualitative research methods are
Table 2 Fatigue and physical
functioning at the three
measurement points
Baseline assessment Post-CBT assessment Long-term follow-up
Fatigue severity
Mean (SD)
46.9 (6.6, 78) 23.7 (11.0) 34.4 (12.4)
Physical functioning
Mean (SD)
66.0 (19.5) 84.7 (15.8) 75.4 (22.5)*
*N = 75
Table 1 Patient characteristics at long-term follow-up assessment (N = 78)
Number (%)
Marital status
Married, living together 59 (76)
Divorced 11(14)
Widowed 3 (4)
Living alone 5 (6)
Gender
Female 38 (49)
Male 40 (51)
Having paid work
Yes 32 (41)
No 46 (59)
Self-reported somatic comorbidity
Yes 32 (41)
No 46 (59)
Significant life events during past
3 months
Yes 24 (31)
No 54 (69)
Treatment by psychologist/psychiatrist
during past 6 months
Yes 11 (14)
No 67 (86)
Current treatment for fatigue complaints
Yes 3 (4)
No 74 (95)
Unknown 1 (1)
Cancer recurrence (currently no treatment,
no metastatic cancer)
Yes 9 (12)
No 69 (88)
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needed to assess the course of fatigue, stressors, and possible
fatigue-perpetuating factors.
There are several possible explanations for the deteriora-
tion after successful treatment of CRF: it is possible that pa-
tients who developed CRF after being treated for cancer had a
pre-existent vulnerability for developing fatigue in response to
a stressor, i.e., a serious somatic illness like cancer. According
to the cognitive-behavioral model of CRF, cancer and its treat-
ment trigger the fatigue but the fatigue perpetuates due to
cognitive-behavioral factors. Perhaps patients remain vulner-
able for developing fatigue in response to stressors. The like-
lihood to encounter one or more serious stressors will increase
over time, this may explain the partial relapse at long-term
follow-up with sustained treatment effects at the follow-up
2 years post-treatment. This vulnerability could also be caused
by cancer and its treatment; up to date, it is largely unclear
how biological processes influence the mechanisms underly-
ing CRF and its persistence. It could be that CBT for CRF
addresses the fatigue but does not change an underlying so-
matic vulnerability which makes cancer survivors prone to
develop severe fatigue. An alternative explanation is that pa-
tients relapse into dysfunctional coping in response to “every-
day” fatigue, and dysfunctional behaviors and cognitions
eventually lead to severe and persistent fatigue. Our outcome
measure at long-term follow-up was restricted to fatigue se-
verity. Measurement of scores on fatigue-perpetuating factors
would have been valuable as well. Insight in these factors at
long-term follow-up would enable us to test whether deterio-
ration of fatigue scores is associated with changes in the per-
petuating factors over time.
The strengths of this study are the long follow-up period
and the high response rate. A limitation of our study is that
the primary outcome variable, the level of fatigue, was mea-
sured only once at long-term follow-up. Patients were only
asked about their level of fatigue in the previous 2 weeks.
Therefore, it remains unclear whether severe fatigue at
Table 3 Levels of fatigue and physical functioning over time
Level of fatigue Level of physical functioning
ß 95% CI p ß 95% CI p
Crude model
Time baseline_FU 12.47 9.75 to 15.20 0,0000000000000006 − 9.06 − 14.05 to − 4.08 0,0004
Time post_FU − 10.71 –13.43 to − 7.98 0,000000000001 9.72 4.73 to 14.70 0,0001
Model with covariates
Time baseline_FU 14.66 11.66 to 17.66 0,000000000000000007 − 15.36 − 21.22 to − 9.51 0,0000006
Time post_FU − 4.65 − 7.70 to − 1.60 0.003 0.42 − 5.47 to 6.30 0.889
Mental health − 0.24 − 0.31 to − 0.16 0,000000002 0.10 − 0.04 to 0.24 0.168
Pain − 0.09 − 0.15 to − 0.03 0.004 0.34 0.23 to 0.45 0,000000007
Cancer recurrence 3.73 − 2.32 to 9.77 0.225 − 0.61 − 12.14 to 10.91 0.916
Self-reported comorbidities 2.58 − 1.53 to 6.70 0.217 − 9.99 − 17.94 to − 2.03 0.014
Significant life events 2.43 − 1.81 to 6.66 0.260 − 4.52 − 12.68 to 3.65 0.277
Notes. Linear mixed model analyses. Time baseline_FU = time between baseline and follow-up assessment; time post_FU = time between post-CBTand
follow-up assessment
Table 4 Multiple regression analysis to predict changes in fatigue severity between post-CBT and long-term follow-up (n = 78)
Predictors Block 1 Block 2
ß SE ß p ß SE ß p
Fatigue severity (CIS-fatigue) 0.351 0.123 0.005 0.103 0.174 0.557
Poor coping with cancer/treatment (IES) – – – − 0.096 0.143 0.504
Activity regulation (CIS-activity) – – – 0.573 0.410 0.211
Dysregulation of sleep (SIP sleep/rest) – – – 0.029 0.030 0.333
Dysfunctional cognitions (SES) – – – − 0.149 0.475 0.755
Discrepancies in social support (SSL-D) – – – 0.387 0.423 0.363
CIS-activity Checklist Individual Strength, subscale activity, CIS-fatigue Checklist Individual Strength, subscale fatigue severity, IES Impact of Events
Scale, SES Self-Efficacy Scale, SIP Sickness Impact Profile, SSL-D = van Sonderen Social Support – Discrepancies
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long-term follow-up was present longer than 2 weeks.
Other limitations are the relatively small sample size and
the fact that we excluded patients who did not complete
CBT. The course of fatigue in this group may be different
from the completers. The exclusion of patients who did not
complete CBT and this assessment may bias our results and
could have caused an overestimation of long-term treat-
ment effects.
Relapse prevention is an important topic in the field of psy-
chotherapy. Various interventions with the aim of preventing
relapse have been developed, especially for depression.
Examples of these are booster sessions, mindfulness, or
metacognitive therapy for depression [19]. The fact that the
relapse following CBT for CRF occurred only after a period
of more than 2 years post-CBT makes it less likely that inter-
ventions aimed at relapse prevention given shortly after termi-
nation of the CBT for CRF will be successful. It seems more
practical and efficient to develop interventions for patients who
are referred again after a relapse of fatigue has occurred. It
should be determined whether patients who have a relapse of
severe fatigue following an initially successful CBT can profit
from booster sessions of CBT again or whether another
evidence-based intervention for fatigue (like mindfulness or
exercise therapy) should be given.
In summary, we found that significant deterioration of fa-
tigue over time occurred, but positive effects of CBTon fatigue
severity were sustained in about half of the participants at long-
term follow-up. Future research should study the underlying
mechanisms of CRF and aim for optimizing the long-term treat-
ment results of CBT for CRF.
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